Pharmaceutical
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
clinical trials
22stories
17 Junlast updated
More in clinical trials
- Clinical Research
How Cannabis Interacts with Pain, Sleep & Anxiety
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and a growing demand for alternatives to conventional pharmaceuticals.
- Pharmaceutical
Europe’s First Ever ‘Whole Plant’ Cannabis Medicine Could be Available by 2026 in Major Step Forward for Non-Opioid Pain Treatment
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval.
- Pharmaceutical
Standard Seed AI’s Platform Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
- Uncategorized
EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on the Brink
In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as part of ongoing efforts by the European Commission to strengthen the continent’s biotechnology and biomanufacturing sectors, which have struggled with fragmented rules and sluggish approval processes.
- Markets & Stocks
Ananda Gets Ethics Approval for Australian Clinical Study, Synbiotic Launches Germany’s First THC-Pastille, & More from Stenocare
UK-based cannabinoid pharmaceutical company Ananda Pharma has received ethics approval for a Phase 1 clinical study for its lead compound in Australia.
- Markets & Stocks
Celadon’s Funding Woes Continue, DanCann Pharma Partners with Tetra Pharma, & Argent Bio Posts Positive Clinical Trial Results
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
- Pharmaceutical
UK Start-up Targets Clinical Proof for Cannabis in Autism Spectrum Disorder
Kingdom Therapeutics, a UK-Irish biotech company, has passed a ‘major milestone’ in its ambitious journey towards launching clinical trials into cannabis and Autism Spectrum Disorder (ASD)
- CBD Market
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds.
